Literature DB >> 27977895

A Soluble Form of P Selectin Glycoprotein Ligand 1 Requires Signaling by Nuclear Factor Erythroid 2-Related Factor 2 to Protect Liver Transplant Endothelial Cells Against Ischemia-Reperfusion Injury.

C Zhang1,2, Y Zhang1,2, Y Liu1,3, Y Liu1,3, S Kageyama1, X-D Shen1, F Gao1, S Zheng2, R W Busuttil1, G D Shaw4, H Ji1, J W Kupiec-Weglinski1.   

Abstract

Liver endothelial cell (LEC) damage is essential in the pathogenesis of ischemia-reperfusion injury (IRI) in transplant recipients. We analyzed the mechanism of LEC resistance against IRI by using a novel recombinant soluble form of P selectin glycoprotein ligand 1, tandem P selectin glycoprotein ligand immunoglobulin (TSGL-Ig), in a mouse model of hepatic cold preservation (4°C in University of Wisconsin solution for 20 h) and syngeneic orthotopic liver transplantation (OLT). Unlike controls, TSGL-Ig protected orthotopic liver transplants against ischemia-reperfusion (IR) stress, shown by depressed serum alanine aminotransferase levels, well-preserved hepatic architecture, and improved survival (42% vs. 92%). TSGL-Ig suppressed neutrophil/macrophage sequestration and proinflammatory cytokine/chemokine programs in OLT. Treatment with TSGL-Ig mitigated LEC activation (P and E selectin, VCAM-1 and intercellular adhesion molecule 1 expression). In parallel in vitro studies, TSGL-Ig diminished cellular damage in H2 O2 -stressed LEC cultures (lactic acid dehydrogenase and alanine aminotransferase levels). Increased thioredoxin, glutamate-cysteine ligase, NAD(P)H quinone dehydrogenase 1, and hypoxia-inducible factor 1α expression, along with transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2), implied that TSGL-Ig exerts antioxidant functions in IR-stressed OLT and H2 O2 -stressed LECs. Indeed, Nrf2-deficient livers suffered fulminant IRI compared with WT despite concomitant TSGL-Ig therapy. Thus, TSGL-Ig is not only acting as a competitive antagonist blocking leukocyte migration into IR-stressed liver, but it may also act directly as an agonist stimulating Nrf2-mediated cytoprotection in LECs. This study supports the role of P selectin signaling in hepatic homeostasis in OLT, with broad implications for tissue damage conditions.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  adhesion molecules/integrins; basic (laboratory) research/science; ischemia reperfusion injury (IRI); liver disease: immune/inflammatory; liver transplantation/hepatology; molecular biology

Mesh:

Substances:

Year:  2017        PMID: 27977895      PMCID: PMC5444987          DOI: 10.1111/ajt.14159

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  34 in total

Review 1.  Selectins in Liver Ischemia and Reperfusion Injury.

Authors:  Ryan T Jones; Luis H Toledo-Pereyra; Kelly M Quesnelle
Journal:  J Invest Surg       Date:  2015-09-16       Impact factor: 2.533

2.  Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.

Authors:  Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Cynthia Y Huang; Catalina Abad; Ronald W Busuttil; James A Waschek; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

3.  P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver.

Authors:  S S Yadav; D N Howell; D A Steeber; R C Harland; T F Tedder; P A Clavien
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

4.  BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.

Authors:  Manabu Furukawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine.

Authors:  S Suzuki; L H Toledo-Pereyra; F J Rodriguez; D Cejalvo
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

Review 6.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

7.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium.

Authors:  K M Mullane; R Kraemer; B Smith
Journal:  J Pharmacol Methods       Date:  1985-11

8.  Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Authors:  T S Dulkanchainun; J A Goss; D K Imagawa; G D Shaw; D M Anselmo; F Kaldas; T Wang; D Zhao; A A Busuttil; H Kato; N G Murray; J W Kupiec-Weglinski; R W Busuttil
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

9.  PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion.

Authors:  Roberto Tinoco; Florent Carrette; Monique L Barraza; Dennis C Otero; Jonathan Magaña; Marcus W Bosenberg; Susan L Swain; Linda M Bradley
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  ROS and ROS-Mediated Cellular Signaling.

Authors:  Jixiang Zhang; Xiaoli Wang; Vikash Vikash; Qing Ye; Dandan Wu; Yulan Liu; Weiguo Dong
Journal:  Oxid Med Cell Longev       Date:  2016-02-22       Impact factor: 6.543

View more
  5 in total

1.  LncRNA Snhg1 Plays an Important Role via Sequestering rno-miR-139-5p to Function as a ceRNA in Acute Rejection After Rat Liver Transplantation Based on the Bioinformatics Analysis.

Authors:  Wu Wu; Menghao Wang; Chunming Li; Zhu Zhu; Yang Zhang; Di Wu; Zhibing Ou; Zuojin Liu
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

2.  Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury.

Authors:  Kishan Kapupara; Yao-Tseng Wen; Rong-Kung Tsai; Shun-Ping Huang
Journal:  Cell Death Dis       Date:  2017-11-16       Impact factor: 8.469

3.  Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.

Authors:  Ravi Vats; Egemen Tutuncuoglu; Tirthadipa Pradhan-Sundd; Jesus Tejero; Gray D Shaw; Prithu Sundd
Journal:  Exp Hematol       Date:  2020-03-31       Impact factor: 3.084

4.  PACAP neuropeptide promotes Hepatocellular Protection via CREB-KLF4 dependent autophagy in mouse liver Ischemia Reperfusion Injury.

Authors:  Zhengze Xue; Yu Zhang; Yuanxing Liu; Cheng Zhang; Xiu-da Shen; Feng Gao; Ronald W Busuttil; Shusen Zheng; Jerzy W Kupiec-Weglinski; Haofeng Ji
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

Review 5.  Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury.

Authors:  Xin-Li Mao; Yue Cai; Ya-Hong Chen; Yi Wang; Xiu-Xiu Jiang; Li-Ping Ye; Shao-Wei Li
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.